{"id":3708,"date":"2026-09-22T08:45:14","date_gmt":"2026-09-22T08:45:14","guid":{"rendered":"https:\/\/celiksoylaw.com\/tr\/approvals\/eb-2-niw-pediatric-immunologist-and-transplantation-researcher\/"},"modified":"2026-10-07T14:32:28","modified_gmt":"2026-10-07T14:32:28","slug":"cocuk-immunologu-ve-organ-nakli-arastirmacisi-icin-eb-2-niw-onayi","status":"publish","type":"approval","link":"https:\/\/celiksoylaw.com\/tr\/onaylar\/cocuk-immunologu-ve-organ-nakli-arastirmacisi-icin-eb-2-niw-onayi\/","title":{"rendered":"\u00c7ocuk Alerji ve \u0130mm\u00fcnoloji Uzman\u0131na EB-2 NIW Onay\u0131"},"content":{"rendered":"<p>Celiksoy Law olarak, \u00e7ocuk alerji ve imm\u00fcnoloji alan\u0131ndaki klinik birikimini organ nakli ara\u015ft\u0131rmalar\u0131na ta\u015f\u0131yan bir uzman hekim i\u00e7in EB-2 National Interest Waiver onay\u0131 ald\u0131k. Ba\u015fvurusunda, ba\u011f\u0131\u015f\u0131kl\u0131k hastal\u0131klar\u0131yla ilgili deneyimini, doktora \u00e7al\u0131\u015fmalar\u0131n\u0131 ve ABD\u2019deki ara\u015ft\u0131rma g\u00f6revini gelecek \u00e7al\u0131\u015fma plan\u0131yla ili\u015fkilendirdik.<\/p>\n<p>Dosyan\u0131n \u00f6nemli ara\u015ft\u0131rma sorular\u0131ndan biri, ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin nakledilen organ\u0131 kabul etmesini sa\u011flayabilecek mekanizmalard\u0131. M\u00fcvekkilimiz, uzun s\u00fcreli ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lay\u0131c\u0131 tedaviye duyulan ihtiyac\u0131n azalt\u0131lmas\u0131n\u0131 hedefleyen ara\u015ft\u0131rmalara kat\u0131l\u0131yordu. Bu y\u00f6nelimin, \u00e7ocukluk \u00e7a\u011f\u0131 alerjileri ve ba\u011f\u0131\u015f\u0131kl\u0131k sistemi bozukluklar\u0131 \u00fczerine olu\u015fturdu\u011fu birikimle ba\u011flant\u0131s\u0131n\u0131 a\u00e7\u0131klad\u0131k.<\/p>\n<h2>Klinik Birikim ve Laboratuvar Deneyimi<\/h2>\n<p>M\u00fcvekkilimiz t\u0131p e\u011fitiminin ard\u0131ndan \u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzmanl\u0131\u011f\u0131n\u0131 ve \u00e7ocuk alerji ve imm\u00fcnoloji e\u011fitimini tamamlad\u0131. Daha sonra molek\u00fcler biyoloji ve genetik alan\u0131nda, imm\u00fcnoloji ve alerji odakl\u0131 doktora yapt\u0131.<\/p>\n<p>Klinik ge\u00e7mi\u015fi, do\u011fu\u015ftan ba\u011f\u0131\u015f\u0131kl\u0131k yetmezliklerinin de\u011ferlendirilmesini ve tedavi s\u00fcre\u00e7lerini kaps\u0131yordu. Kan yap\u0131c\u0131 k\u00f6k h\u00fccre nakillerine ili\u015fkin deneyimi de ba\u011f\u0131\u015f\u0131kl\u0131k mekanizmalar\u0131n\u0131n tedavideki \u00f6nemini ara\u015ft\u0131rma konular\u0131yla ili\u015fkilendiren bir temel olu\u015fturuyordu.<\/p>\n<p>Doktora \u00e7al\u0131\u015fmas\u0131nda, h\u00fccrelerin salg\u0131lad\u0131\u011f\u0131 k\u00fc\u00e7\u00fck par\u00e7ac\u0131klar olan h\u00fccre d\u0131\u015f\u0131 vezik\u00fcllerin ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131tlar\u0131yla ili\u015fkisini inceledi. \u00c7ocukluk \u00e7a\u011f\u0131ndaki enfeksiyonlarla ilgili bu \u00e7al\u0131\u015fma, h\u00fccresel mekanizmalar\u0131 ara\u015ft\u0131rma deneyimini a\u00e7\u0131klamak a\u00e7\u0131s\u0131ndan dosyada yer ald\u0131.<\/p>\n<p>E\u011fitim belgeleri, mesleki kay\u0131tlar ve bilimsel \u00e7al\u0131\u015fmalar \u00fczerinden bu iki y\u00f6n\u00fc birlikte sunduk: hastal\u0131klar\u0131n klinik kar\u015f\u0131l\u0131\u011f\u0131n\u0131 bilen bir hekim olmas\u0131 ve ayn\u0131 sorunlar\u0131 laboratuvar d\u00fczeyinde inceleyebilmesi. Bu ba\u011flant\u0131, ABD\u2019deki ara\u015ft\u0131rma hedeflerinin mesleki ge\u00e7mi\u015fine nas\u0131l dayand\u0131\u011f\u0131n\u0131 g\u00f6stermemize yard\u0131mc\u0131 oldu.<\/p>\n<h2>Organ Naklinde Ba\u011f\u0131\u015f\u0131kl\u0131k Tolerans\u0131<\/h2>\n<p>Nakil ara\u015ft\u0131rmalar\u0131ndaki \u00e7al\u0131\u015fma plan\u0131, al\u0131c\u0131n\u0131n ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin ba\u011f\u0131\u015flanan organ\u0131 kabul etmesine odaklan\u0131yordu. Bu alanda \u201cdon\u00f6re \u00f6zg\u00fc tolerans\u201d olarak ifade edilen hedef, ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131t\u0131n\u0131n nakledilen organ bak\u0131m\u0131ndan daha elveri\u015fli h\u00e2le gelmesini ara\u015ft\u0131rmay\u0131 i\u00e7eriyordu.<\/p>\n<p>M\u00fcvekkilimizin kat\u0131ld\u0131\u011f\u0131 \u00e7al\u0131\u015fmalar aras\u0131nda b\u00f6brek ve kemik ili\u011fi naklinin birlikte uygulanmas\u0131 sonras\u0131nda geli\u015fen ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131tlar\u0131n\u0131n incelenmesi bulunuyordu. Don\u00f6r ve al\u0131c\u0131ya ait kan yap\u0131c\u0131 h\u00fccrelerin bir arada bulunmas\u0131, tolerans mekanizmalar\u0131n\u0131n ara\u015ft\u0131r\u0131ld\u0131\u011f\u0131 yakla\u015f\u0131mlardan biriydi.<\/p>\n<p>Dosya ayr\u0131ca domuzdan insana b\u00f6brek nakliyle ilgili ara\u015ft\u0131rmalara kat\u0131l\u0131m\u0131n\u0131 da anlat\u0131yordu. Bu \u00e7al\u0131\u015fmalar, uygun insan don\u00f6r organlar\u0131n\u0131n s\u0131n\u0131rl\u0131 olmas\u0131 sorununa y\u00f6nelik farkl\u0131 bir ara\u015ft\u0131rma alan\u0131n\u0131 temsil ediyordu.<\/p>\n<p>Her iki konuda da m\u00fcvekkilimizin ortak projelerdeki rol\u00fcn\u00fc ve planlanan \u00e7al\u0131\u015fmalar\u0131n potansiyel \u00f6nemini a\u00e7\u0131klad\u0131k. Organ reddinin \u00f6nlenmesi ve ila\u00e7 ihtiyac\u0131n\u0131n azalt\u0131lmas\u0131, ara\u015ft\u0131rmalar\u0131n ula\u015fmay\u0131 hedefledi\u011fi klinik yararlard\u0131. Ba\u015fvuruda bu hedefler, mevcut bilimsel deneyimin \u00fczerine kurulacak \u00e7al\u0131\u015fmalarla ili\u015fkilendirildi.<\/p>\n<h2>Yay\u0131nlar\u0131n Dosyaya Katk\u0131s\u0131<\/h2>\n<p>M\u00fcvekkilimizin ortak yazarl\u0131 yay\u0131nlar\u0131 hem ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin i\u015fleyi\u015fini hem de klinik de\u011ferlendirme sorunlar\u0131n\u0131 ele al\u0131yordu. H\u00fccre d\u0131\u015f\u0131 vezik\u00fcllerin ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri \u00fczerindeki etkilerini inceleyen ara\u015ft\u0131rmas\u0131n\u0131n yan\u0131nda, \u00e7ocuklarda eozinofili, kal\u0131tsal ba\u011f\u0131\u015f\u0131kl\u0131k bozukluklar\u0131 ve besin alerjileri \u00fczerine \u00e7al\u0131\u015fmalar\u0131 bulunuyordu.<\/p>\n<p>Bu yay\u0131nlar\u0131n konular\u0131n\u0131 a\u00e7\u0131klamak, bilimsel ge\u00e7mi\u015finin i\u00e7eri\u011fini g\u00f6r\u00fcn\u00fcr k\u0131ld\u0131. Hangi hastal\u0131klar\u0131 ve mekanizmalar\u0131 inceledi\u011fi, klinik deneyimini ara\u015ft\u0131rmaya nas\u0131l ta\u015f\u0131d\u0131\u011f\u0131 ve bu birikimin gelecek plan\u0131yla ili\u015fkisi dosyada birlikte ele al\u0131nd\u0131.<\/p>\n<p>Ba\u015fka ara\u015ft\u0131rmac\u0131lar\u0131n bu \u00e7al\u0131\u015fmalara yapt\u0131\u011f\u0131 at\u0131flardan \u00f6rnekler de sunduk. At\u0131f belgeleri, yay\u0131nlar\u0131n bilimsel literat\u00fcrde nas\u0131l kullan\u0131ld\u0131\u011f\u0131na ili\u015fkin ba\u011flam sa\u011flad\u0131. Ara\u015ft\u0131rmalar\u0131n i\u00e7eri\u011fi ve meslekta\u015f de\u011ferlendirmeleri de bu anlat\u0131m\u0131 destekledi.<\/p>\n<p>Kongre sunumlar\u0131, belirli poster \u00e7al\u0131\u015fmalar\u0131na verilen \u00f6d\u00fcller ve bir ara\u015ft\u0131rma projesine sa\u011flanan destek, bilimsel faaliyetlerinin di\u011fer y\u00f6nleriydi. Kitap \u00e7al\u0131\u015fmalar\u0131ndaki yard\u0131mc\u0131 edit\u00f6rl\u00fck, b\u00f6l\u00fcm yazarl\u0131\u011f\u0131 ve \u00e7eviri katk\u0131lar\u0131 da ayr\u0131 g\u00f6revler olarak belirtildi.<\/p>\n<h2>Ba\u015fvuruyu Destekleyen Kan\u0131tlar<\/h2>\n<p>Dosyada belirtilen belgeleri, m\u00fcvekkilimizin akademik haz\u0131rl\u0131\u011f\u0131, ara\u015ft\u0131rma deneyimi ve ABD\u2019deki hedefleri aras\u0131ndaki ili\u015fkiyi a\u00e7\u0131klamak i\u00e7in kulland\u0131k.<\/p>\n<div class=\"cl-ap-tbl\">\n<table>\n<thead>\n<tr>\n<th>Ba\u015fvuruda belirtilen kan\u0131t<\/th>\n<th>Dosyadaki i\u015flevi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>T\u0131p, uzmanl\u0131k ve doktora e\u011fitimine ili\u015fkin kay\u0131tlar<\/td>\n<td>Ba\u015fvurunun akademik temelini ve klinik-bilimsel haz\u0131rl\u0131\u011f\u0131n\u0131 destekledi.<\/td>\n<\/tr>\n<tr>\n<td>\u00c7al\u0131\u015fma kay\u0131tlar\u0131 ve ara\u015ft\u0131rma g\u00f6revi atama yaz\u0131lar\u0131<\/td>\n<td>Mesleki ge\u00e7mi\u015fini ve ABD\u2019deki ara\u015ft\u0131rma ortam\u0131n\u0131 belgeledi.<\/td>\n<\/tr>\n<tr>\n<td>ABD\u2019deki \u00e7al\u0131\u015fma plan\u0131<\/td>\n<td>Ba\u011f\u0131\u015f\u0131kl\u0131k mekanizmalar\u0131, hedefe y\u00f6nelik tedaviler ve nakil ara\u015ft\u0131rmalar\u0131na ili\u015fkin hedeflerini tan\u0131mlad\u0131.<\/td>\n<\/tr>\n<tr>\n<td>Bilimsel makaleler ve ara\u015ft\u0131rma profilleri<\/td>\n<td>Tamamlanm\u0131\u015f bilimsel \u00e7al\u0131\u015fmalar\u0131n\u0131 ve ele ald\u0131\u011f\u0131 konular\u0131 g\u00f6sterdi.<\/td>\n<\/tr>\n<tr>\n<td>Yay\u0131nlar\u0131na at\u0131f yapan \u00e7al\u0131\u015fmalardan \u00f6rnekler<\/td>\n<td>Ara\u015ft\u0131rmalar\u0131n\u0131n ba\u015fka bilimsel yay\u0131nlarda nas\u0131l kullan\u0131ld\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/td>\n<\/tr>\n<tr>\n<td>Klinik ve ara\u015ft\u0131rma meslekta\u015flar\u0131n\u0131n referans mektuplar\u0131<\/td>\n<td>Deneyimi, ara\u015ft\u0131rma becerileri ve ortak \u00e7al\u0131\u015fmalardaki katk\u0131lar\u0131 hakk\u0131nda de\u011ferlendirmeler sundu.<\/td>\n<\/tr>\n<tr>\n<td>Poster \u00f6d\u00fclleri ve proje deste\u011fi belgeleri<\/td>\n<td>Belirli \u00e7al\u0131\u015fmalar\u0131na verilen takdiri ve ara\u015ft\u0131rma deste\u011fini belgeledi.<\/td>\n<\/tr>\n<tr>\n<td>Kongre ve dergi hakemli\u011fi kay\u0131tlar\u0131<\/td>\n<td>Bilimsel payla\u015f\u0131m\u0131n\u0131 ve ba\u015fka ara\u015ft\u0131rmac\u0131lar\u0131n \u00e7al\u0131\u015fmalar\u0131n\u0131 de\u011ferlendirme deneyimini g\u00f6sterdi.<\/td>\n<\/tr>\n<tr>\n<td>Kitap katk\u0131lar\u0131 ve ara\u015ft\u0131rma e\u011fitimi belgeleri<\/td>\n<td>Bilimsel e\u011fitim faaliyetlerini ve ara\u015ft\u0131rma uygulamalar\u0131na ili\u015fkin haz\u0131rl\u0131\u011f\u0131n\u0131 destekledi.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2>\u00c7al\u0131\u015fma Plan\u0131 ve NIW Talebi<\/h2>\n<p>Ba\u015fvuruda planlanan ara\u015ft\u0131rmalar\u0131n de\u011ferini ve daha geni\u015f \u00f6nemini, m\u00fcvekkilimizin bunlar\u0131 ilerletmeye y\u00f6nelik haz\u0131rl\u0131\u011f\u0131n\u0131 ve i\u015f teklifi ile i\u015fg\u00fcc\u00fc sertifikasyonu \u015fartlar\u0131ndan muafiyet talebinin gerek\u00e7elerini a\u00e7\u0131klad\u0131k.<\/p>\n<p>Nakil tolerans\u0131 ve ba\u011f\u0131\u015f\u0131kl\u0131k hastal\u0131klar\u0131 \u00fczerine \u00e7al\u0131\u015fmalar\u0131n, tek bir ara\u015ft\u0131rma pozisyonunun \u00f6tesindeki potansiyel etkisini ele ald\u0131k. ABD\u2019deki ara\u015ft\u0131rma g\u00f6revi plan\u0131n uygulanabilece\u011fi ortam\u0131 a\u00e7\u0131klarken, yay\u0131nlar ve referans mektuplar\u0131 da m\u00fcvekkilimizin bu \u00e7al\u0131\u015fmalara haz\u0131rl\u0131\u011f\u0131n\u0131 destekliyordu.<\/p>\n<p>Dosyan\u0131n b\u00fct\u00fcn\u00fcnde e\u011fitim ge\u00e7mi\u015fi, klinik deneyim, laboratuvar \u00e7al\u0131\u015fmalar\u0131 ve gelecekteki hedefler birbirini tamamlad\u0131. B\u00f6ylece mesleki birikiminin hangi ara\u015ft\u0131rma sorular\u0131na y\u00f6neldi\u011fini ve bu \u00e7al\u0131\u015fmalar\u0131n neden \u00f6nem ta\u015f\u0131yabilece\u011fini somut bi\u00e7imde sunduk.<\/p>\n<h2>EB-2 NIW Onay\u0131<\/h2>\n<p>USCIS, m\u00fcvekkilimizin EB-2 NIW kapsam\u0131ndaki I-140 ba\u015fvurusunu onaylad\u0131. Bu vaka, bir hekimin uzmanl\u0131k alan\u0131ndaki klinik deneyimi ile laboratuvar ara\u015ft\u0131rmalar\u0131n\u0131n ayn\u0131 \u00e7al\u0131\u015fma plan\u0131 etraf\u0131nda nas\u0131l ili\u015fkilendirilebilece\u011fini g\u00f6steriyor.<\/p>\n<p><a href=\"https:\/\/celiksoylaw.com\/tr\/amerika-gocmenlik\/eb-2-niw-ulusal-cikar-muafiyeti\/\">EB-2 NIW ba\u015fvurusu<\/a> d\u00fc\u015f\u00fcnen hekimler ve ara\u015ft\u0131rmac\u0131lar i\u00e7in de\u011ferlendirme, mesleki ge\u00e7mi\u015fin i\u00e7eri\u011fini ve planlanan \u00e7al\u0131\u015fmalar\u0131n dayand\u0131\u011f\u0131 kan\u0131tlar\u0131 birlikte ele almal\u0131d\u0131r. Ba\u015fvuru se\u00e7eneklerinizi g\u00f6r\u00fc\u015fmek i\u00e7in <a href=\"mailto:us@celiksoylaw.com\">us@celiksoylaw.com<\/a> adresinden bize ula\u015fabilirsiniz.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ba\u011f\u0131\u015f\u0131kl\u0131k hastal\u0131klar\u0131 ve organ naklinde tolerans \u00fczerine \u00e7al\u0131\u015fan bir uzman hekim i\u00e7in EB-2 NIW onay\u0131 ald\u0131k. Klinik deneyimini, doktora ara\u015ft\u0131rmas\u0131n\u0131 ve ABD\u2019deki \u00e7al\u0131\u015fma plan\u0131n\u0131 birlikte sunduk.<\/p>\n","protected":false},"featured_media":4595,"menu_order":24,"template":"","meta":{"cl_author_id":0,"ap_case_type":"EB-2 NIW","ap_applicant":"\u00c7ocuk Alerji ve \u0130mm\u00fcnoloji Uzman\u0131 ve Ara\u015ft\u0131rmac\u0131 Hekim","ap_focus_label":"Uzmanl\u0131k Alan\u0131","ap_focus":"\u00c7ocuk \u0130mm\u00fcnolojisi, Alerjik Hastal\u0131klar, Nakil \u0130mm\u00fcnolojisi ve Ba\u011f\u0131\u015f\u0131kl\u0131k Tolerans\u0131","ap_approval_type":"I-140 G\u00f6\u00e7men Dilek\u00e7esi Onay\u0131","ap_notice":5444,"ap_profile":"[[\"Dosya t\u00fcr\u00fc\",\"EB-2 National Interest Waiver\"],[\"Ba\u015fvuru sahibi\",\"\u00c7ocuk Alerji ve \u0130mm\u00fcnoloji Uzman\u0131 ve Ara\u015ft\u0131rmac\u0131 Hekim\"],[\"Akademik ge\u00e7mi\u015f\",\"T\u0131p E\u011fitimi, \u00c7ocuk Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Uzmanl\u0131\u011f\u0131 ve Molek\u00fcler Biyoloji ve Genetik Doktoras\u0131\"],[\"Ara\u015ft\u0131rma oda\u011f\u0131\",\"Ba\u011f\u0131\u015f\u0131kl\u0131k Sistemi Bozukluklar\u0131, \u00c7ocukluk \u00c7a\u011f\u0131 Alerjileri ve Nakil \u0130mm\u00fcnolojisi\"],[\"ABD\u2019deki \u00e7al\u0131\u015fma hedefi\",\"Ba\u011f\u0131\u015f\u0131kl\u0131k Mekanizmalar\u0131, Hedefe Y\u00f6nelik Tedaviler ve Organ Naklinde Tolerans Ara\u015ft\u0131rmalar\u0131\"],[\"Onay t\u00fcr\u00fc\",\"I-140 G\u00f6\u00e7men Dilek\u00e7esi Onay\u0131\"]]","ap_card_title":"\u00c7ocuk Alerji ve \u0130mm\u00fcnoloji Uzman\u0131na EB-2 NIW Onay\u0131","ap_hide_notice":"","footnotes":""},"approval_type":[34],"approval_region":[37],"class_list":["post-3708","approval","type-approval","status-publish","has-post-thumbnail","hentry","approval_type-eb-2-niw","approval_region-us"],"_links":{"self":[{"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval\/3708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval"}],"about":[{"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/types\/approval"}],"version-history":[{"count":5,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval\/3708\/revisions"}],"predecessor-version":[{"id":5432,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval\/3708\/revisions\/5432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/media\/4595"}],"wp:attachment":[{"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/media?parent=3708"}],"wp:term":[{"taxonomy":"approval_type","embeddable":true,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval_type?post=3708"},{"taxonomy":"approval_region","embeddable":true,"href":"https:\/\/celiksoylaw.com\/tr\/wp-json\/wp\/v2\/approval_region?post=3708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}